Skip to content

Johnson & Johnson (JNJ) stock: revenue, earnings & dividend

Johnson & Johnson (JNJ, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener JNJ · NYSE Pharma & Biotech US-NJ

Key figures

Fiscal year
2025
Revenue
94.2 bn $
Revenue growth
6.1 %
Revenue growth 5y (p.a.)
2.7 %
Net income
26.8 bn $
Net margin
28.5 %
Operating margin
–
Earnings per share (diluted)
11.03 $
Dividend per share
5.14 $
Payout ratio
46.6 %
Consecutive dividend years
17 years
Consecutive dividend raises
16 years
Dividend growth 5y (p.a.)
5.3 %
Total assets
199 bn $
Equity
81.5 bn $
Equity ratio
40.9 %
Return on equity
32.9 %
Cash
19.7 bn $
Operating cash flow
24.5 bn $
Free cash flow
19.7 bn $
Shares outstanding
2,407,310,266

History

Revenue by fiscal year

2016 71.9 bn $
2017 76.5 bn $
2018 81.6 bn $
2019 82.1 bn $
2020 82.6 bn $
2021 78.7 bn $
2022 80 bn $
2023 85.2 bn $
2024 88.8 bn $
2025 94.2 bn $

Net income by fiscal year

2016 16.5 bn $
2017 1.3 bn $
2018 15.3 bn $
2019 15.1 bn $
2020 14.7 bn $
2021 20.9 bn $
2022 17.9 bn $
2023 35.2 bn $
2024 14.1 bn $
2025 26.8 bn $

Dividend per share

2016 3.15 $
2017 3.32 $
2018 3.54 $
2019 3.75 $
2020 3.98 $
2021 4.19 $
2022 4.45 $
2023 4.70 $
2024 4.91 $
2025 5.14 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202594.2 bn $26.8 bn $11.03 $5.14 $24.5 bn $
202488.8 bn $14.1 bn $5.79 $4.91 $24.3 bn $
202385.2 bn $35.2 bn $13.72 $4.70 $22.8 bn $
202280 bn $17.9 bn $6.73 $4.45 $21.2 bn $
202178.7 bn $20.9 bn $7.81 $4.19 $23.4 bn $
202082.6 bn $14.7 bn $5.51 $3.98 $23.5 bn $
201982.1 bn $15.1 bn $5.63 $3.75 $23.4 bn $
201881.6 bn $15.3 bn $5.61 $3.54 $22.2 bn $
201776.5 bn $1.3 bn $0.47 $3.32 $21.1 bn $
201671.9 bn $16.5 bn $5.93 $3.15 $18.8 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)